Biblio

Export 351 results:
[ Author(Desc)] Title Type Year
Filters: First Letter Of Title is C  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
S. Abu-Rumeileh, Mometto, N., Bartoletti-Stella, A., Polischi, B., Oppi, F., Poda, R., Stanzani-Maserati, M., Cortelli, P., Liguori, R., Capellari, S., and Parchi, P., “Cerebrospinal Fluid Biomarkers in Patients with Frontotemporal Dementia Spectrum: A Single-Center Study.”, J Alzheimers Dis, vol. 66, no. 2, pp. 551-563, 2018.
M. Ejaz Ahmed, Iyer, S., Thangavel, R., Kempuraj, D., Selvakumar, G. Pushpavath, Raikwar, S. P., Zaheer, S., and Zaheer, A., “Co-Localization of Glia Maturation Factor with NLRP3 Inflammasome and Autophagosome Markers in Human Alzheimer's Disease Brain.”, J Alzheimers Dis, vol. 60, no. 3, pp. 1143-1160, 2017.
C. Akiba, Nakajima, M., Miyajima, M., Ogino, I., Motoi, Y., Kawamura, K., Adachi, S., Kondo, A., Sugano, H., Tokuda, T., Irie, K., and Arai, H., “Change of Amyloid-β 1-42 Toxic Conformer Ratio After Cerebrospinal Fluid Diversion Predicts Long-Term Cognitive Outcome in Patients with Idiopathic Normal Pressure Hydrocephalus.”, J Alzheimers Dis, vol. 63, no. 3, pp. 989-1002, 2018.
S. Akoudad, M Gurol, E., Fotiadis, P., Koudstaal, P. J., Hofman, A., M Ikram, A., Greenberg, S. M., and Vernooij, M. W., “Cerebral Microbleeds and Cerebrovascular Reactivity in the General Population: The EDAN Study.”, J Alzheimers Dis, vol. 53, no. 2, pp. 497-503, 2016.
P. Alexopoulos, Soldatos, R., Kontogianni, E., Frouda, M., Aligianni, S. Loanna, Skondra, M., Passa, M., Konstantopoulou, G., Stamouli, E., Katirtzoglou, E., Politis, A., Economou, P., Alexaki, M., Siarkos, K., and Politis, A., “COVID-19 Crisis Effects on Caregiver Distress in Neurocognitive Disorder.”, J Alzheimers Dis, vol. 79, no. 1, pp. 459-466, 2021.
M. L. Alosco, Sugarman, M. A., Besser, L. M., Tripodis, Y., Martin, B., Palmisano, J. N., Kowall, N. W., Au, R., Mez, J., DeCarli, C., Stein, T. D., McKee, A. C., Killiany, R. J., and Stern, R. A., “A Clinicopathological Investigation of White Matter Hyperintensities and Alzheimer's Disease Neuropathology.”, J Alzheimers Dis, vol. 63, no. 4, pp. 1347-1360, 2018.
N. Altomari, Bruno, F., Laganà, V., Smirne, N., Colao, R., Curcio, S., Di Lorenzo, R., Frangipane, F., Maletta, R., Puccio, G., and Bruni, A. Cecilia, “A Comparison of Behavioral and Psychological Symptoms of Dementia (BPSD) and BPSD Sub-Syndromes in Early-Onset and Late-Onset Alzheimer's Disease.”, J Alzheimers Dis, vol. 85, no. 2, pp. 691-699, 2022.
Á
I. Álvarez, Aguilar, M., González, J. Manuel, Ysamat, M., Lorenzo-Bosquet, C., Alonso, A., Tartari, J. Pablo, Romero, S., Diez-Fairen, M., Carcel, M., Pujalte, F., and Pastor, P., “Clinic-Based Validation of Cerebrospinal Fluid Biomarkers with Florbetapir PET for Diagnosis of Dementia.”, J Alzheimers Dis, vol. 61, no. 1, pp. 135-143, 2018.
A
D. G. Amen, Krishnamani, P., Meysami, S., Newberg, A., and Raji, C. A., “Classification of Depression, Cognitive Disorders, and Co-Morbid Depression and Cognitive Disorders with Perfusion SPECT Neuroimaging.”, J Alzheimers Dis, vol. 57, no. 1, pp. 253-266, 2017.
D. Andriuta, Si-Ahmed, C., Roussel, M., Constans, J. - M., Makki, M., Aarabi, A., Basille, D., Andrejak, C., and Godefroy, O., “Clinical and Imaging Determinants of Neurocognitive Disorders in Post-Acute COVID-19 Patients with Cognitive Complaints.”, J Alzheimers Dis, vol. 87, no. 3, pp. 1239-1250, 2022.
S. Angermann, Schier, J., Baumann, M., Steubl, D., Hauser, C., Lorenz, G., Günthner, R., Braunisch, M. C., Kemmner, S., Satanovskij, R., Haller, B., Heemann, U., Lehnert, T., Bieber, R., Pachmann, M., Braun, J., Scherf, J., Schätzle, G., Fischereder, M., Grimmer, T., and Schmaderer, C., “Cognitive Impairment is Associated with Mortality in Hemodialysis Patients.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1529-1537, 2018.
I. Apostolova, Lange, C., Roberts, A., Igel, H. Joachim, Mäurer, A., Liese, S., Estrella, M., Prasad, V., Stechl, E., Lämmler, G., Steinhagen-Thiessen, E., and Buchert, R., “Challenges in Screening and Recruitment for a Neuroimaging Study in Cognitively Impaired Geriatric Inpatients.”, J Alzheimers Dis, vol. 56, no. 1, pp. 197-204, 2017.
G. Arendash, Cao, C., Abulaban, H., Baranowski, R., Wisniewski, G., Becerra, L., Andel, R., Lin, X., Zhang, X., Wittwer, D., Moulton, J., Arrington, J., and Smith, A., “A Clinical Trial of Transcranial Electromagnetic Treatment in Alzheimer's Disease: Cognitive Enhancement and Associated Changes in Cerebrospinal Fluid, Blood, and Brain Imaging.”, J Alzheimers Dis, vol. 71, no. 1, pp. 57-82, 2019.
A. Arighi, Di Cristofori, A., Fenoglio, C., Borsa, S., D'Anca, M., Fumagalli, G. Giulio, Locatelli, M., Carrabba, G., Pietroboni, A. Margherita, Ghezzi, L., Carandini, T., Colombi, A., Scarioni, M., De Riz, M. Alessandra, Serpente, M., Rampini, P. Maria, Scarpini, E., and Galimberti, D., “Cerebrospinal Fluid Level of Aquaporin4: A New Window on Glymphatic System Involvement in Neurodegenerative Disease?”, J Alzheimers Dis, vol. 69, no. 3, pp. 663-669, 2019.
J. J. Armstrong, Godin, J., Launer, L. J., White, L. R., Mitnitski, A., Rockwood, K., and Andrew, M. K., “Changes in Frailty Predict Changes in Cognition in Older Men: The Honolulu-Asia Aging Study.”, J Alzheimers Dis, vol. 53, no. 3, pp. 1003-13, 2016.
S. P. Arnerić, Batrla-Utermann, R., Beckett, L., Bittner, T., Blennow, K., Carter, L., Dean, R., Engelborghs, S., Genius, J., Gordon, M. Forrest, Hitchcock, J., Kaplow, J., Luthman, J., Meibach, R., Raunig, D., Romero, K., Samtani, M. N., Savage, M., Shaw, L., Stephenson, D., Umek, R. M., Vanderstichele, H., Willis, B., and Yule, S., “Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: A View of the Regulatory Science Qualification Landscape from the Coalition Against Major Diseases CSF Biomarker Team.”, J Alzheimers Dis, vol. 55, no. 1, pp. 19-35, 2017.
E. Aso, Andrés-Benito, P., Carmona, M., Maldonado, R., and Ferrer, I., “Cannabinoid Receptor 2 Participates in Amyloid-β Processing in a Mouse Model of Alzheimer's Disease but Plays a Minor Role in the Therapeutic Properties of a Cannabis-Based Medicine.”, J Alzheimers Dis, vol. 51, no. 2, pp. 489-500, 2016.
B
N. Baazaoui and Iqbal, K., “COVID-19 and Neurodegenerative Diseases: Prion-Like Spread and Long-Term Consequences.”, J Alzheimers Dis, vol. 88, no. 2, pp. 399-416, 2022.
A. Baird, Brancatisano, O., Gelding, R., and Thompson, W. Forde, “Characterization of Music and Photograph Evoked Autobiographical Memories in People with Alzheimer's Disease.”, J Alzheimers Dis, vol. 66, no. 2, pp. 693-706, 2018.
C. Balducci, Paladini, A., Micotti, E., Tolomeo, D., La Vitola, P., Grigoli, E., Richardson, J. C., and Forloni, G., “The Continuing Failure of Bexarotene in Alzheimer's Disease Mice.”, J Alzheimers Dis, 2015.
M. Balietti, Giuli, C., Fattoretti, P., Fabbietti, P., Postacchini, D., and Conti, F., “Cognitive Stimulation Modulates Platelet Total Phospholipases A2 Activity in Subjects with Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 50, no. 4, pp. 957-62, 2016.
K. J. Bangen, Clark, A. L., Werhane, M., Edmonds, E. C., Nation, D. A., Evangelista, N., Libon, D. J., Bondi, M. W., and Delano-Wood, L., “Cortical Amyloid Burden Differences Across Empirically-Derived Mild Cognitive Impairment Subtypes and Interaction with APOE ɛ4 Genotype.”, J Alzheimers Dis, vol. 52, no. 3, pp. 849-61, 2016.
F. O. Bastian, “Combined Creutzfeldt-Jakob/ Alzheimer's Disease Cases are Important in Search for Microbes in Alzheimer's Disease.”, J Alzheimers Dis, vol. 56, no. 3, pp. 867-873, 2017.
S. Beesley, Olcese, J., Saunders, C., and Bienkiewicz, E. A., “Combinatorial Treatment Effects in a Cell Culture Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1155-1166, 2017.
I. Beheshti, Maikusa, N., Daneshmand, M., Matsuda, H., Demirel, H., and Anbarjafari, G., “Classification of Alzheimer's Disease and Prediction of Mild Cognitive Impairment Conversion Using Histogram-Based Analysis of Patient-Specific Anatomical Brain Connectivity Networks.”, J Alzheimers Dis, vol. 60, no. 1, pp. 295-304, 2017.

Pages